← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
126	Guggenheim Capital Chicago, Illinois	$180M	+$179M	20	0.76%	New
127	Amundi Asset Management US Boston, Massachusetts	$178M	+$175M	7	0.74%	New
128	Rockefeller Financial Services New York	$175M	+$178M	8	4.2%	New
129	Select Equity Group New York	$173M	+$175M	4	2.44%	New
130	MCM Mason Capital Management New York	$172M	+$169M	1	3.44%	New
131	LCG Luxor Capital Group New York	$171M	+$168M	1	4.63%	New
132	Fred Alger Management New York	$171M	+$171M	5	1.02%	New
133	First Manhattan New York	$170M	+$162M	9	1.17%	New
134	Principal Financial Group Des Moines, Iowa	$170M	+$168M	16	0.38%	New
135	Panagora Asset Management Boston, Massachusetts	$169M	+$163M	14	0.87%	New
136	Mackenzie Financial Toronto Ontario, Ontario, Canada	$169M	+$164M	5	0.81%	New
137	First Trust Advisors Wheaton, Illinois	$166M	+$167M	11	1.08%	New
138	Samlyn Capital New York	$166M	+$162M	2	4.84%	New
139	NFA Nationwide Fund Advisors Columbus, Ohio	$163M	+$159M	17	0.86%	New
140	BAMCO Inc New York	$163M	+$144M	2	0.85%	New
141	LBG Lloyds Banking Group London, United Kingdom	$162M	+$159M	5	1.7%	New
142	Davis Selected Advisers Tucson, Arizona	$160M	+$162M	2	0.41%	New
143	OppenheimerFunds New York	$159M	+$155M	5	0.23%	New
144	MTB Mizuho Trust & Banking Tokyo, Japan	$157M	+$155M	5	0.66%	New
145	BlackRock Japan Tokyo, Japan	$156M	+$153M	8	0.72%	New
146	Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada	$156M	+$154M	6	0.45%	New
147	CCI Columbus Circle Investors	$155M	+$154M	6	1.25%	New
148	Frontier Capital Management Boston, Massachusetts	$154M	+$145M	5	1.28%	New
149	Hotchkis & Wiley Capital Management Los Angeles, California	$151M	+$155M	1	0.75%	New
150	Robeco Schweiz Zurich, Switzerland	$150M	+$146M	3	13.49%	New